NEWS & ACTIVITIES

From December 5 to 7, 2025 , EG Bio participated in iSWAM Jakarta 2025 alongside Genèse Labs France , advancing its strategic expansion in Indonesia and ASEAN markets. iSWAM (International Symposium on Aesthetic Medicine) typically hosts 2,500+ doctors , 150+ exhibitors , and participants from across the Asia-Pacific region, making it a key congress for professional aesthetic medicine. At iSWAM Jakarta 2025, EG Bio and Genèse Labs France showcased advanced regenerative and i

From October 21 to 23, 2025 , EG Bio participated in InterCHARM Moscow 2025 together with Genèse Labs France , reinforcing engagement with CIS and Eastern European partners. InterCHARM Moscow is one of the largest professional beauty and aesthetics exhibitions in the region, typically attracting 60,000+ visitors , 1,000+ exhibitors , and companies from 40+ countries . At the exhibition, EG Bio and Genèse Labs France presented their latest portfolio developments and met with

From October 16 to 18, 2025 , EG Bio participated in AMWC Latin America 2025 in Medellín together with Genèse Labs France , continuing its structured expansion across Latin American markets. AMWC Latin America typically welcomes 3,000+ medical professionals , 200+ exhibitors , and participants from across Central and South America, making it one of the region’s most important aesthetic medicine congresses. At the congress, EG Bio and Genèse Labs France showcased their latest

From July 24 to 26, 2025 , EG Bio attended Vietbeauty 2025 together with Genèse Labs France , strengthening its footprint in Southeast Asia. Vietbeauty is one of Vietnam’s leading beauty and aesthetics exhibitions, typically hosting 10,000+ trade visitors , 600+ exhibitors , and participants from 25+ countries , serving as a key gateway to ASEAN markets. During the exhibition, EG Bio and Genèse Labs France showcased their newest product innovations and engaged with regional

From April 14 to 16, 2025 , EG Bio participated in Dubai Derma 2025 alongside Genèse Labs France , strengthening engagement across Middle Eastern markets. Dubai Derma is the largest dermatology and aesthetic exhibition in the Middle East, typically attracting 20,000+ visitors , 1,500+ brands , and professionals from 100+ countries . The exhibition plays a central role in shaping regional distribution frameworks, regulatory pathways, and commercial partnerships. At Dubai Derm

From March 27 to 29, 2025 , EG Bio Co., Ltd. participated in AMWC Monaco 2025 together with its strategic partner Genèse Labs France , reinforcing its presence at the most influential global event in medical aesthetics. AMWC Monaco is widely regarded as the world’s leading aesthetic and anti-aging medicine congress, typically welcoming 15,000+ attendees , 900+ exhibiting companies , and participants from 130+ countries . The event combines high-level scientific education wi

Expanding ancillary products for professional aesthetic procedures In February 2025 , EG Bio Co., Ltd. expanded its professional product lineup with the introduction of the X-Caine and X-Pro numbing cream series, strengthening its ancillary offerings for aesthetic procedures. The X-Caine and X-Pro series were introduced to support procedural comfort across a wide range of professional aesthetic treatments. By adding these products to its portfolio, EG Bio aims to provide d

Introducing a new hyaluronic acid filler line for international markets In January 2025 , Rèluma HA Filler , a new hyaluronic acid filler line developed by Genèse Labs France , was officially launched and added to EG Bio Co., Ltd. ’s global distribution portfolio. Rèluma HA Filler was introduced as part of Genèse Labs France’s expanding injectable portfolio, designed for professional aesthetic applications and structured international market entry. The product line reflects a

From November 21 to 23, 2024 , EG Bio participated in AMWC Asia 2024 in Bangkok, continuing its active engagement with distributors and professionals across the Asia-Pacific region. During the congress, EG Bio held meetings with partners from multiple Asian markets to discuss distribution frameworks, market access strategies, and long-term collaboration opportunities. Discussions focused on aligning product portfolios with regional needs and supporting sustainable growth acr